Article

Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-resistant Lung Cancer

2021-01-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Lung cancer has become a global health issue in recent decades. Despite of high rate of resistance, cisplatin-base chemotherapy is still the main treatment of lung cancer patients who are not suitable for TKI-based targeted therapy and immunotherapy. Thus, overcoming cisplatin resistance is urgently needed.<bold>Methods</bold>A small panel is established to screen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 427b43c2-2959-5791-88a9-709d0bee893d
DOI: 10.21203/rs.3.rs-141062/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-resistant Lung CancerDOI 10.21203/rs.3.rs-141062/v1Read

The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cellsSemantic proximity Read

Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic StrategiesSemantic proximity Read

Transcriptome analysis reveals PRKCA as a potential therapeutic target for overcoming cisplatin resistance in lung cancer through ferroptosisSemantic proximity Read

Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapySemantic proximity Read

<i>Calotropis gigantea</i> extract induces apoptosis through extrinsic/intrinsic pathways and upregulation of reactive oxygen species in non-small-cell lung cancer cellsSemantic proximity Read

Resistin increases cisplatin-induced cytotoxicity in lung adenocarcinoma A549 cells via a mitochondria-mediated pathwaySemantic proximity Read

Cancer cell killing via ROS: To increase or decrease, that is the questionSemantic proximity Read

Vulnerability of Antioxidant Drug Therapies on Targeting Nrf2-Trp53-Jdp2 Axis in Controlling the TumorigenesisSemantic proximity Read

DNA Damage Response Network and Intracellular Redox Status in the Clinical Outcome of Lung Cancer PatientsSemantic proximity Read

The Roles of ROS in Cancer Heterogeneity and TherapySemantic proximity Read

Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second AlterationSemantic proximity Read

Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedureSemantic proximity Read